Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.
1:13-cv-01524
Overview
Parties
Defendant
Par Pharmaceutical Inc. Operating Company
Represented By
7 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Par Pharmaceutical Companies Inc. Operating Company
Represented By
3 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Defendant
Takeda Pharmaceuticals USA Inc. Operating Company
Represented By
10 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.
Patents Involved
There are 17 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7906519
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-15
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2010-05-25
Issued: 2011-05-03
|
Active (3.5 yrs remaining)
Expires: 2030-05-25
|
|
|
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-18
Issued: 2012-01-10
|
Active (4.5 yrs remaining)
Expires: 2031-05-18
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
|
|
US7964648
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-01-15
Issued: 2011-06-21
|
Active (3.2 yrs remaining)
Expires: 2030-01-15
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
51
Dispositive
2
Granted
2
Denied
0
Pending / Review
38
Motions by Category
Key Dispositive Motions & Rulings